Who is sponsoring NCT03748602?

NCT03748602 is sponsored by Catharina Ziekenhuis Eindhoven.

What drugs are being tested in NCT03748602?

Interventions in NCT03748602: Thoracic outlet decompression.

What condition does NCT03748602 study?

NCT03748602 studies Neurogenic Thoracic Outlet Syndrome.

Is NCT03748602 still recruiting?

NCT03748602 is currently status unknown. Last updated 29 July 2022.

Last reviewed 2022-07-29 · How we verify

NCT03748602: STOPNTOS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surgical Thoracic Outlet Decompression for Neurogenic Thoracic Outlet Syndrome

Status unknown NA Last updated 29 July 2022

What this trial tests

NA trial testing Thoracic outlet decompression in Neurogenic Thoracic Outlet Syndrome in 50 participants. Status unknown.

Timeline

1 October 2018

Primary endpoint
1 October 2024

1 October 2024

Quick facts

Lead sponsor	Catharina Ziekenhuis Eindhoven
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 October 2018
Primary completion	1 October 2024
Estimated completion	1 October 2024
Sites	1 location across Netherlands

Drugs / interventions tested

Thoracic outlet decompression

Conditions studied

Neurogenic Thoracic Outlet Syndrome — all drugs for Neurogenic Thoracic Outlet Syndrome →

Sponsor

Catharina Ziekenhuis Eindhoven — full company profile →

Who can join

18 and older, any sex, with Neurogenic Thoracic Outlet Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will determine the value of TOD (first rib resection with partial scalenectomy and neurolysis) on functionality and quality of life for patients with neurogenic thoracic outlet syndrome. This will be done by randomizing patients into surgery or conservative therapy (physiotherapy and pain relief).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neurogenic Thoracic Outlet Syndrome

Currently open trials in the same condition.

NCT06172101 — Free Fat Flap In Recurrent Neurogenic Thoracic Outlet Syndrome Surgical Treatment · recruiting

Other Catharina Ziekenhuis Eindhoven trials

Trials by the same sponsor.

NCT07314138 — Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-pump Coronar · NA · not yet recruiting
NCT06768060 — Mindfulness-based Intervention Prior to External Cephalic Version · NA · recruiting
NCT06574867 — Evaluation of the viQtor Monitoring Solution on Surgical Wards · recruiting
NCT06374836 — The Contractile Response of the Thoracic Aorta to Vasoactive Substances · completed
NCT06401291 — Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03748602 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Catharina Ziekenhuis Eindhoven
Last refreshed: 29 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03748602.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing